Agency Forms Undergoing Paperwork Reduction Act Review, 2509-2510 [2019-01325]

Download as PDF 2509 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents Form name NBCCEDP Grantees ....................................................................................... MDES ............ Jeffrey M. Zirger, Acting Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention (CDC). [FR Doc. 2019–01327 Filed 2–6–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30-Day–19–18JC] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled ‘‘Women’s Health Needs Study: The Health of U.S.Resident Women from Countries with Prevalent Female Genital Mutilation/ Cutting (FGM/C)’’ to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on March 20, 2018 to obtain comments from the public and affected agencies. CDC received three comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; VerDate Sep<11>2014 17:23 Feb 06, 2019 Jkt 247001 (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Women’s Health Needs Study: The Health of U.S.-Resident Women from Countries with Prevalent Female Genital Mutilation/Cutting (FGM/C)—New— National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Female Genital Mutilation/Cutting (FGM/C) is a practice common in many countries; in parts of Asia, Africa and the Middle East that can have severe, deleterious health consequences for women and girls. Recent studies suggest that more than 500,000 women and girls in the United States may have been cut or be at risk for FGM/C based on whether women or their mothers are from countries with high prevalence of FGM/C. However, this estimate was derived using indirect techniques that do not account for the differing characteristics of women in the country PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 Number of respondents 70 Number of responses per respondent 2 Average burden per response (in hours) 150/60 of origin versus those who have migrated to the United States, or any other factors that are likely to affect the prevalence of FGM/C. Additional major knowledge gaps regarding FGM/C in the United States include: The prevalence of FGM/C in selected communities in the United States with high concentrations of residents from countries where FGM/C is prevalent; women’s attitudes about continuance of the practice; and the health characteristics and needs of women living in the United States who have experienced FGM/C or are at risk for FGM/C. This study aims to capture information on women’s history of FGM/C, their experiences with health care services, and their attitudes about continuation of the FGM/C practice. Findings from this study will be used to identify public health needs of women and communities in the United States that are affected by FGM/C, to formulate public health strategies to meet identified needs, and to inform prevention efforts. The proposed information collection will include piloting and conducting a full-scale survey of the health experiences and needs of women who live in selected communities in the United States with high concentrations of residents from countries where FGM/ C is widely practiced. The pilot study will be conducted during the first year of this project and will be used to assess the feasibility of sampling and recruiting methods for a hard-to-reach population on a sensitive topic. Based on findings from the pilot, a change request, including necessary translations, will be submitted to conduct the full study during the second and third year of this project. The full study is planned to be implemented in up to five community sites in the United States. The estimated annualized burden over the three years of this project is 356 hours. There are no costs to respondents other than their time to participate. E:\FR\FM\07FEN1.SGM 07FEN1 2510 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Total number of respondents Number of responses per respondents Time per response (hours) Type of respondent Form name Women age 18 to 49 who were born in, or whose mother was born in, an FGM/C practicing country. Women age 18–49 who were born in, or whose mother was born in, an FGM/C practicing country. WHNS Eligibility Screener ..... 667 1 5/60 WHNS Questionnaire ............ 400 1 45/60 Jeffrey M. Zirger, Acting Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–01325 Filed 2–6–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60-Day–19–1108; Docket No. CDC–2018– 0117] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Paul Coverdell National Acute Stroke Program (PCNASP) reporting system, which was established to improve quality of care for acute stroke patients from onset of signs and symptoms through hospital care and rehabilitation and recovery. DATES: CDC must receive written comments on or before April 8, 2019. ADDRESSES: You may submit comments, identified by Docket No. CDC–2018– 0117 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. SUMMARY: VerDate Sep<11>2014 17:23 Feb 06, 2019 Jkt 247001 Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project Paul Coverdell National Acute Stroke Program (PCNASP) (OMB No. 0920– 1108, exp. 03/31/2019)—Revision— National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Stroke is the fifth leading cause of death in the United States and results in approximately 130,000 deaths per year. Additionally, approximately 800,000 stroke events are reported each year, including approximately 250,000 recurrent strokes. However, many strokes are preventable, or patient outcomes post-stroke can be improved through coordinated care that begins at stroke onset and is delivered in a timely manner. Stroke outcomes depend upon the rapid recognition of signs and symptoms of stroke, prompt transport to a treatment facility, and early rehabilitation. Improving outcomes requires a coordinated systems approach involving pre-hospital care, emergency department and hospital care, post-stroke rehabilitation, prevention of complications, and ongoing secondary prevention. Each care setting has unique opportunities for improving the quality of care provided and access to available professional and clinical care at the local level within a coordinated state-based system of care. Through the Paul Coverdell National Acute Stroke Program (PCNASP), CDC has been continuously working to measure and improve acute stroke care using well-known quality improvement strategies coupled with frequent evaluation of results. PCNASP awardees are state health departments who work with participating hospitals, Emergency E:\FR\FM\07FEN1.SGM 07FEN1

Agencies

[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2509-2510]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01325]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day-19-18JC]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Women's Health Needs Study: The Health of 
U.S.-Resident Women from Countries with Prevalent Female Genital 
Mutilation/Cutting (FGM/C)'' to the Office of Management and Budget 
(OMB) for review and approval. CDC previously published a ``Proposed 
Data Collection Submitted for Public Comment and Recommendations'' 
notice on March 20, 2018 to obtain comments from the public and 
affected agencies. CDC received three comments related to the previous 
notice. This notice serves to allow an additional 30 days for public 
and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Women's Health Needs Study: The Health of U.S.-Resident Women from 
Countries with Prevalent Female Genital Mutilation/Cutting (FGM/C)--
New--National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Female Genital Mutilation/Cutting (FGM/C) is a practice common in 
many countries; in parts of Asia, Africa and the Middle East that can 
have severe, deleterious health consequences for women and girls. 
Recent studies suggest that more than 500,000 women and girls in the 
United States may have been cut or be at risk for FGM/C based on 
whether women or their mothers are from countries with high prevalence 
of FGM/C. However, this estimate was derived using indirect techniques 
that do not account for the differing characteristics of women in the 
country of origin versus those who have migrated to the United States, 
or any other factors that are likely to affect the prevalence of FGM/C. 
Additional major knowledge gaps regarding FGM/C in the United States 
include: The prevalence of FGM/C in selected communities in the United 
States with high concentrations of residents from countries where FGM/C 
is prevalent; women's attitudes about continuance of the practice; and 
the health characteristics and needs of women living in the United 
States who have experienced FGM/C or are at risk for FGM/C.
    This study aims to capture information on women's history of FGM/C, 
their experiences with health care services, and their attitudes about 
continuation of the FGM/C practice. Findings from this study will be 
used to identify public health needs of women and communities in the 
United States that are affected by FGM/C, to formulate public health 
strategies to meet identified needs, and to inform prevention efforts.
    The proposed information collection will include piloting and 
conducting a full-scale survey of the health experiences and needs of 
women who live in selected communities in the United States with high 
concentrations of residents from countries where FGM/C is widely 
practiced. The pilot study will be conducted during the first year of 
this project and will be used to assess the feasibility of sampling and 
recruiting methods for a hard-to-reach population on a sensitive topic. 
Based on findings from the pilot, a change request, including necessary 
translations, will be submitted to conduct the full study during the 
second and third year of this project. The full study is planned to be 
implemented in up to five community sites in the United States. The 
estimated annualized burden over the three years of this project is 356 
hours. There are no costs to respondents other than their time to 
participate.

[[Page 2510]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of       Time per
          Type of respondent                    Form name          Total number    responses per     response
                                                                  of respondents    respondents       (hours)
----------------------------------------------------------------------------------------------------------------
Women age 18 to 49 who were born in,    WHNS Eligibility                     667               1            5/60
 or whose mother was born in, an FGM/C   Screener.
 practicing country.
Women age 18-49 who were born in, or    WHNS Questionnaire......             400               1           45/60
 whose mother was born in, an FGM/C
 practicing country.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-01325 Filed 2-6-19; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.